Page last updated: 2024-10-24

bupivacaine and SUNCT Syndrome

bupivacaine has been researched along with SUNCT Syndrome in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

SUNCT Syndrome: A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Porta-Etessam, J1
Cuadrado, ML1
Galán, L1
Sampedro, A1
Valencia, C1

Other Studies

1 other study available for bupivacaine and SUNCT Syndrome

ArticleYear
Temporal response to bupivacaine bilateral great occipital block in a patient with SUNCT syndrome.
    The journal of headache and pain, 2010, Volume: 11, Issue:2

    Topics: Aged, 80 and over; Amines; Anesthetics, Local; Anticonvulsants; Bupivacaine; Cyclohexanecarboxylic A

2010